- -11%
- New
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
Accutane is Dragon Pharma's formulation of Isotretinoin at 20mg per tablet — a powerful oral retinoid used for severe, treatment-resistant acne. Supplied in a 100-tablet pack, Isotretinoin works by significantly reducing sebaceous gland activity, addressing acne at its source rather than treating individual breakouts.
Also searched as: Isotretinoin 20mg, Accutane tabs, oral retinoid acne treatment, Accutane Dragon Pharma.
Isotretinoin is a vitamin A derivative (retinoid) that reduces the size and activity of sebaceous glands, the skin's oil-producing glands. By significantly decreasing sebum production, Isotretinoin addresses the underlying cause of severe acne — excess oil combined with clogged pores and bacterial activity — rather than managing symptoms topically. It is typically reserved for severe, cystic or treatment-resistant acne that has not responded to topical treatments or antibiotics.
Androgenic anabolic steroids — particularly those with higher androgenic ratings — commonly increase sebum production and can trigger or worsen acne, including on the back and chest ("bacne") in addition to facial acne. For users experiencing severe, cystic acne during a cycle that doesn't respond to standard topical treatments, Isotretinoin is sometimes used as a more aggressive intervention. However, Isotretinoin does not address the underlying hormonal cause (elevated androgens) — it manages the skin's response. Reducing the androgenic load of a cycle, where possible, addresses the cause directly.
| Phase | Typical Dose | Duration |
|---|---|---|
| Initial dose | 0.5 mg/kg/day | First 4 weeks, often |
| Standard course | 0.5–1 mg/kg/day | 15–20 weeks total, typically |
Isotretinoin is typically dosed based on body weight, starting at a lower dose and potentially increasing based on response and tolerability. A full course often runs several months, with the goal of reaching a cumulative dose associated with sustained remission. Dosing should be guided by a healthcare provider given the significant side effect profile and monitoring requirements.